Filing Details
- Accession Number:
- 0001062993-15-003849
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-14 14:58:37
- Reporting Period:
- 2015-07-14
- Filing Date:
- 2015-07-14
- Accepted Time:
- 2015-07-14 14:58:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1314052 | Anavex Life Sciences Corp. | AVXL | Services-Commercial Physical & Biological Research (8731) | 208365999 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1196573 | U Christopher Missling | 51 W 52Nd Street, 7Th Floor New York NY 10019-6163 | President, Ceo, Cfo, Treasurer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-14 | 1,000 | $0.52 | 4,013,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 3, 2015.
- Includes 4,000,000 shares of restricted common stock, 3,000,000 shares of which have vested pursuant to the achievement of certain objectives.
Billionaire Hedge Funds
